PolicyJuly 23, 2018
Will Trump’s Plans Bring Down Drug Prices?
Healthcare experts seek to unpack the bold and the bluster in the varying proposals
Stories by Erin Mershon
MedicineJuly 19, 2018
FDA Chief Slams Drugmakers for Stalling Release of Biosimilars
Americans could have saved $4.5 billion last year if these products were more available, agency official says
MedicineMay 11, 2018
Trump Denounces “Middlemen” and Largely Spares Pharma in Drug Pricing Speech
The White House proposal would not allow Medicare to negotiate prices or expand medication imports
MedicineNovember 16, 2017
Trump Rails against Drug Industry, but Turns to Its Ranks to Fill Administration
Some Republicans argue industry players can use their experience to pursue reforms
PolicySeptember 19, 2017
Under GOP Health Care Bill, States Would Struggle to Hang onto Obamacare
States that expanded Medicaid would be particularly hard hit
PolicyAugust 14, 2017
FDA Puts New Restrictions on Hiring Foreign Scientists
Documents suggest the limits are linked to background check hurdles
Public HealthJune 22, 2017
Is the Senate Health Care Plan “Mean”?
Short answer: it depends